NCT05118035

Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality

Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality: a Pragmatic Randomized Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 15,965 (actual)
• Sponsor: National Defense Medical Center, Taiwan · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for early detection of clinical deterioration for reducing mortality.

Conditions

• Cardiovascular Diseases
• Intensity Care
• Morality

Interventions

Type	Name	Description
OTHER	AI-enabled ECG-based Screening Tool	Primary care clinicians in the intervention group had access to the report, which shows the risk prediction results for each patients. Moreover, the clinicians will recieve a short message when patients with a high risk ECG identified by AI.

Timeline

• Start date: 2021-12-15
• Primary completion: 2022-04-30
• Completion: 2022-12-31
• First posted: 2021-11-11
• Last updated: 2023-02-08

Locations

1 site across 1 country: Taiwan